E-LIB Suche - Ergebnisse für: Brothers, Joel

1

Oral Abstract: HL-642 Does Interim PET Assessment After Two..:

Samaeekia, Ravand ; Brothers, Joel ; Mirshahidi, Hamid.
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S147 , 2023

Link: https://doi.org/10.1016/..

2

Recurrent and atypical immune checkpoint inhibitor-induced ..:

Jeon, Won Jin ; Nguyen, Jasmine ; Castillo, Dani Ran...
Journal of Oncology Pharmacy Practice. 29 (2023) 5 - p. 1264-1267 , 2023

Link: https://doi.org/10.1177/..

3

HL-642 Does Interim PET Assessment After Two Cycles of Trea..:

Samaeekia, Ravand ; Brothers, Joel ; Mirshahidi, Hamid.
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S413-S414 , 2023

Link: https://doi.org/10.1016/..

4

Partial response to venetoclax and ruxolitinib combination ..:

Brothers, Joel ; Castillo, Dan Ran ; Jeon, Won Jin..
Hematology. 28 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

5

Case Report: An exceptional response to neoadjuvant radioth..:

Jeon, Won Jin ; Moon, Jin Hyun ; Pham, Bryan...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Factors Influencing Physician Discretion to Administer CNS ..:

Hino, Christopher ; Lacy, Curtis ; Brothers, Joel...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 10 - p. 764-771 , 2023

Link: https://doi.org/10.1016/..

7

Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle..:

Castillo, Dani Ran ; Park, Daniel ; Jeon, Won Jin...
International Journal of Molecular Sciences. 24 (2023) 12 - p. 10207 , 2023

Link: https://doi.org/10.3390/..

8

POSTER: HL-642 Does Interim PET Assessment After Two Cycles..:

Samaeekia, Ravand ; Brothers, Joel ; Mirshahidi, Hamid.
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S198 , 2023

Link: https://doi.org/10.1016/..

9

Incidental radiologic findings at breast cancer diagnosis a..:

Brothers, Joel M. ; Kidwell, Kelley M. ; Brown, Richard K. J..
Breast Cancer Research and Treatment. 155 (2016) 2 - p. 395-403 , 2016

Link: https://doi.org/10.1007/..

10

Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle..:

Castillo, Dani Ran ; Park, Daniel ; Jeon, Won Jin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298847/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Current Observations in the Management of Hypo- and Hyperco..:

Gish, Robert G ; Brothers, Joel M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191818/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle..:

Dani Ran Castillo ; Daniel Park ; Won Jin Jeon...
https://www.mdpi.com/1422-0067/24/12/10207. , 2023

Link: https://doi.org/10.3390/..

13

Partial response to venetoclax and ruxolitinib combination ..:

Joel Brothers ; Dan Ran Castillo ; Won Jin Jeon..
https://www.tandfonline.com/doi/10.1080/16078454.2023.2237342. , 2023

Link: https://doi.org/10.1080/..

14

Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle..:

Dani Ran Castillo ; Daniel Park ; Won Jin Jeon...
Molecular Oncology. , 2023

Link: https://doi.org/10.3390/..

15

Case Report: An exceptional response to neoadjuvant radioth..:

Won Jin Jeon ; Jin Hyun Moon ; Bryan Pham...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1198292/full. , 2023

Link: https://doi.org/10.3389/..